To clarify the mechanism of TFAP2A in pancreatic cancer, we first analyzed the TCGA and GTEx databases and compared the expressions as well as survival differences of TFAP2A in tumors (n=179) and normal tissues (n=171). This evidence concerns the gene TFAP2A and familial pancreatic carcinoma.